Muscular Dystrophy ICD-10: The G71.0 Codes by Subtype

Muscular dystrophy ICD-10 coding starts at G71.0-, and the first thing to know is that G71.0- will not bill. It is a parent code requiring a further character, and the character you choose depends entirely on how specific the genetic diagnosis in the record is.

Muscular dystrophy ICD-10 codes at a glance

Why G71.0- rejects

G71.0 is non-billable because it is a subcategory heading rather than a diagnosis. The claim needs the fourth character, and often a fifth or sixth.

There is a documentation rule behind the formatting one. G71.00, muscular dystrophy unspecified, clears the billing edit, which makes it a tempting default. It is also a wasted code on a patient whose chart records a genetic diagnosis. Where the neurology note or the genetic report names the subtype, the specific code is correct and the unspecified code is a last resort.

Duchenne and Becker share one code

G71.01 covers both Duchenne and Becker muscular dystrophy. They are clinically distinct, with different ages of onset and trajectories, but ICD-10-CM classifies them together because both arise from dystrophin gene mutations.

There is no fifth character to separate them, so do not go looking for one. The clinical distinction lives in the documentation and in the drug and procedure coding rather than in the diagnosis code.

The limb girdle codes are the ones to check

Limb girdle is where the code set has moved most, and where an out-of-date crosswalk causes rejections.

G71.03 is a sub-subcategory covering the limb girdle muscular dystrophies, and it needs a further character. Most of its children are five characters: G71.031 autosomal dominant, G71.032 calpain-3, G71.033 dysferlin, G71.035 anoctamin-5, G71.036 fukutin related protein, G71.038 other, and G71.039 unspecified.

The exception is the sarcoglycan branch. G71.034 is itself a subdivision, not a valid code. It resolves to six characters: G71.0340 unspecified, G71.0341 alpha, G71.0342 beta, G71.0349 other. A claim submitted with G71.034 is rejected as invalid, and it is common enough to be worth a targeted edit check.

Because these codes track specific protein defects, they are assignable only where the record supports the defect. A genetic report naming calpain-3 supports G71.032. An impression of "limb girdle muscular dystrophy" with no subtype identified supports G71.039, not a guess at which protein is involved.

Emery-Dreifuss has no code of its own

This is the question that sends coders in circles, so the answer is worth stating flatly: there is no dedicated code for Emery-Dreifuss muscular dystrophy.

It is captured at G71.09, other specified muscular dystrophies, which carries as an inclusion term "benign scapuloperoneal muscular dystrophy with early contractures [Emery-Dreifuss]". The same code also covers congenital muscular dystrophy, distal, ocular, oculopharyngeal and scapuloperoneal muscular dystrophy.

G71.09 is an "other specified" code: the correct destination for a named condition with no code of its own. G71.00 means the subtype was not established. The two are not interchangeable, and confusing them makes a well-documented chart look vague.

Myotonic dystrophy is somewhere else

Myotonic dystrophy, also called Steinert disease, is not in the G71.0- family. It sits at G71.11, myotonic muscular dystrophy, within the myotonic disorders subcategory alongside myotonia congenita (G71.12) and drug-induced myotonia (G71.14).

The name contains the words muscular dystrophy, which is exactly why the miscode happens. Searching the tabular list under G71.0- will not find it.

Excludes notes and related families

G71.0 carries an Excludes2 for arthrogryposis multiplex congenita (Q74.3), metabolic disorders (E70-E88) and myositis (M60.-). Excludes2 means the excluded condition is not part of this code, but both may be reported together where both are documented.

Muscle wasting recorded elsewhere in the chart is a separate assignment. Generalised age-related loss belongs at M62.84, covered in our sarcopenia ICD-10 guide; disease-driven systemic wasting belongs at R64 or E88.A, covered in our cachexia ICD-10 guide. Neither substitutes for the dystrophy code.

The pathway behind the diagnosis

The reason this site tracks these codes is that muscular dystrophy has been the primary testing ground for myostatin inhibition.

Myostatin, or GDF-8, restrains skeletal muscle growth, and blocking it was expected to add muscle to boys losing it. Duchenne in particular attracted a long run of programmes, and the results have been sobering rather than encouraging. We go through every major trial in myostatin and Duchenne muscular dystrophy.

Sources

• ICD-10-CM code G71.0, Muscular dystrophy, AAPC Codify.
• ICD-10-CM code G71.09, Other specified muscular dystrophies, AAPC Codify.
• ICD-10-CM code G71.0340, LGMD due to sarcoglycan dysfunction, unspecified, AAPC Codify.
• NLM Clinical Table Search Service, ICD-10-CM, current code list.

Frequently asked questions